Knowledge Vault - Alkermes Medical Affairs

Infographics & Posters

See What Others Don't: Serious Mental Illness

New

Overview of Positive and Negative Syndrome Scale (PANSS)

Educational Programs

Educational Programs are delivered by an Alkermes Medical Science Liaison in-person or online.

At-Risk States and Early Psychosis in Serious Mental Illness

Description

Objectives of the Presentation are to:

Review the potential clinical course of early psychosis and how patients are assessed to be at ultra-high risk for psychosis
Discuss how duration of untreated psychosis may impact treatment outcomes
Explore disease and functional trajectories in early mental illness
Review barriers to treatment in early serious mental illness
Discuss coordinated specialty care and clinical data examining its effectiveness

Request MSL Presentation

Connect with Alkermes Medical Affairs

Inquiry*

Name*

Email*

Phone

City, State*

Institution

Credentials

Select contact preferences:

Phone

This form is for U.S. healthcare professionals only. Alkermes collects and uses the personal information you provide to address your MSL request. For information on how we handle your information, please review our privacy policy. Please do not use this form to share any patient information. By providing your information and clicking the button, you indicate that you agree to these terms and conditions.

To report suspected adverse reactions, please contact Alkermes at 1-888-235-8008 or FDA at 1-800-FDA-1088 or http://www.fda.gov/medwatch.